Michael Smigelski

Levine Cancer Institute, New York University

Papers

2

Total Citations

9

H-Index

2

About

Dr. Michael Smigelski is a urologic surgeon and researcher whose work focuses on advancing minimally invasive surgical techniques for the treatment of kidney and prostate cancers. His key research areas include robotic partial nephrectomy, salvage therapies for recurrent prostate cancer, and the management of post-surgical complications. Dr. Smigelski’s major contributions include a contemporary single-center analysis of urine leak and vascular complications following robotic partial nephrectomy, which provides critical insights into improving patient outcomes and surgical safety. He also pioneered a novel salvage treatment for locally recurrent prostate cancer, combining cryoablation of the prostate with robotic seminal vesiculectomy, offering a new option for patients who have failed radiation therapy. His work has garnered early recognition, with his most cited papers accumulating 5 and 4 citations respectively, reflecting growing interest in his innovative approaches. Dr. Smigelski’s research is notable for its focus on practical, patient-centered solutions that address challenging clinical scenarios, making him a promising voice in the field of urologic oncology and robotic surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
9
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Urine leak and vascular complications following robotic partial nephrectomy: a contemporary single-center experience
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Levine Cancer Institute, New York University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago